Search PubMed⌕ Search

Biomedical subjects

B Dick

Publications and source records attributed to B Dick.

At least 37 records · Page 2Linked to original sources

[Capsular bent ring. Improvement of the capsular tension ring].

Since the first introduction of the capsular ring in 1991, the open capsular tension ring proved to be efficient in various indications and applications: e.g. in zonular dialysis or or weakness, with integrated tinted sector shield in sector or aniridia, to facilitate primary posterior capsulorhexis, for prophylaxis of intraocular lens decentration or as an intraocular measuring gauge. Nishi modified this capsular tension ring mainly by increasing the width to 0.7 mm and created a rectangular edge, thus facilitating the creation of a sharp, discontinuous bend in the equatorial capsule. This band-shaped, sharp-edged capsule-bending ring prevented the anterior capsule from coming into contact with the posterior capsule. This is most likely due to the 0.7 mm width of the capsule-bending ring, which significantly prevented anterior capsule opacification, which commonly occurs within one month postoperatively. Posterior capsule opacification seems to be reduced as well, but final evaluation is needed for a longer period of time. The capsular tension ring as well as the capsular bending ring enlarge our surgical options in modern cataract surgery. Both can be considered as a useful instrument and promising innovation.

Aged↗

[Classification of visco-elastic substances for ophthalmologic surgery].

UNLABELLED: Individual properties of a viscoelastic substance for ophthalmologic applications are intimately tied to its chemical and rheologic characteristics. Independent comparative data for vicoelastic substances are not readily available or interpretable. MATERIAL AND METHODS: Twenty-six different commercially available viscoelastic substances were investigated using the Advanced Rheometric Expansion System and the Rheometric Scientific 800 device to analyze elastic and viscous modulus, complex viscosity (dynamic frequency dependance) and viscosity at the zero shear rate by extrapolation using the Ellis fit. RESULTS: Viscosity (cps) at zero shear rate (s-1, mean of six different samples): Sodium hyaluronate products: Amivisc Plus: 128; AMO Vitrax: 41; Biolon: 243; Dispasan: 130; Dispasan Plus: 782; Healon: 243; Healon GV: 2451; Healon 5: 5525; Microvisc (Morcher Oil): 1162; Microvisc Plus: 3663; Morcher Oil: 1253; Provisc: 207; Rayvisc: 78; Viscoat: 58; Viscorneal (Allervisc): 733; Viscorneal Plus (Allervisc Plus): 1176; Visko: 206; Visko Plus: 1683. Hydroxypropylmethylcellulose (HPMC) products: Acrivisc: 7; Adatocel: 8; Coatel: 6; HPMC Ophthal H: 94; HPMC Ophthal L: 7; Ocucoat: 6; PeHa-Visko: 5; Visco Shield: 60. CONCLUSION: Sodium hyaluronate as well as HPMC viscoelastic substances demonstrated remarkable differences in rheological properties from each other. In some cases, the results of this independent investigation differed from the values provided by the companies. A new division of commercially available viscoelastic substances into subgroups is presented, which provides a scientific base for various practical viscosurgical aspects. These real rheologic properties of each substance allow the ophthalmic surgeon to choose the viscoelastic substance that is most suitable for the surgical situation.

Adjuvants, Immunologic↗

Retinal vascular occlusion and deficiencies in the protein C pathway.

PURPOSE: To report abnormalities in the protein C pathway and other vascular occlusion risk factors in patients with retinal vascular occlusion. METHODS: In a study, we investigated 76 consecutive patients who had in-patient evaluation of venous or arterial retinal vascular occlusion. All patients underwent comprehensive tests for coagulation disorders including determinations of protein C, protein S, lupus anticoagulants, and resistance to activated protein C and were screened for vascular disease risk factors. Resistance to activated protein C was confirmed by a polymerase chain reaction method to detect the specific factor V R506Q mutation. For comparative purposes, we also screened 209 consecutive inpatients with deep vein thrombosis from the same geographic region for resistance to activated protein C as well as protein C and protein S deficiencies. RESULTS: Ten (29%) of 35 patients with central retinal vein occlusion (CRVO) had factor V R506Q mutation. The factor V R506Q mutation was detected in four (19%) of 21 patients with branch retinal vein occlusion. The higher frequency in factor V R506Q mutation compared with the expected 9% mutation prevalence in a white population was highly significant for the central retinal vein occlusion group but not for the branch retinal vein occlusion group. In all patients with resistance to activated protein C, the factor V R506Q mutation was detected; 16 were heterozygous, one homozygous. No cases of lupus anticoagulants, protein C, or protein S deficiencies were detected. Forty (19%) of 209 patients with deep vein thrombosis were carriers of the factor V R506Q mutation. CONCLUSIONS: The prevalence of the factor V R506Q mutation is similar in patients with central retinal vein occlusion and patients with deep vein thrombosis and represents a relevant risk factor. Screening for this mutation is therefore recommended in all patients with central retinal vein occlusion.

Activated Protein C Resistance↗

Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2.

Salt-sensitive subjects (SS) increase their blood pressure with increasing salt intake. Because steroid hormones modulate renal sodium retention, we hypothesize that the activity of the 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) enzyme is impaired in SS subjects as compared with salt-resistant (SR) subjects. The 11betaHSD2 enzyme inactivates 11-hydroxy steroids in the kidney, thus protecting the nonselective mineralocorticoid receptor from occupation by glucocorticoids. We performed an association study using a recently identified single AluI polymorphism in exon 3 and a polymorphic microsatellite marker of the HSD11B2 gene in 149 normotensive white males (37 SS and 112 SR). The activity of the enzyme 11betaHSD2 was assessed by determining the urinary ratio of cortisol (THF+5alphaTHF) to cortisone (THE) metabolites by gas chromatography in all the 37 SS subjects and in 37 age- and body habitus-matched SR volunteers. Mean (THF+5alphaTHF)/THE ratio was markedly elevated in SS subjects compared with SR subjects (1.51 +/- 0.34 vs. 1.08 +/- 0.26, P < 0.00001), indicating enhanced access of glucocorticoids to the mineralocorticoid receptor in SS subjects. In 58% of SS subjects this ratio was higher than the maximum levels in SR subjects. The salt-induced elevation in arterial pressure increased with increasing (THF+5alphaTHF)/THE ratio (r2 = 0.51, P < 0.0001). A total of 12 alleles of the polymorphic microsatellite marker were detected. Homozygosity for the allele A7 was higher in SS subjects than in SR subjects (41 vs. 28%, P < 0.005), whereas the occurrence of the allele A7 with allele A8 was lower in SS subjects than in SR subjects (8 vs. 15%, P < 0.03). The prevalence of salt sensitivity was 35% in subjects with allele A7/A7, whereas salt sensitivity was present in only 9% of the subjects with allele A7/A8. The (THF+5alphaTHF)/THE ratio was higher in subjects homozygous for the A7 microsatellite allele as compared with the corresponding control subjects. The prevalence of the AluI allele was 8.0% in SR subjects and 5.4% in SS subjects and did not correlate with blood pressure. The decreased activity of the 11betaHSD2 in SS subjects indicates that this enzyme is involved in salt-sensitive blood pressure response in humans. The association of a polymorphic microsatellite marker of the gene with a reduced 11betaHSD2 activity suggests that variants of the HSD 11B2 gene contribute to enhanced blood pressure response to salt in humans.

11-beta-Hydroxysteroid Dehydrogenases↗

Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome.

Patients with the nephrotic syndrome (NS) exhibit abnormal renal sodium retention which cannot completely explained by a secondary hyperaldosteronism due to reduced renal perfusion. As an alternative mechanism to explain this phenomenon we postulate a cortisol-mediated mineralocorticoid effect as a consequence of a reduced activity of 11beta-hydroxysteroid dehydrogenase (11beta-HSD). A down-regulation of 11beta-HSD, i.e. of the shuttle of active to inactive glucocorticosteroids, has been shown to cause mineralocorticoid effects. Therefore we investigated the activity of 11beta-HSD by measuring the urinary ratio of (tetrahydrocortisol + 5alpha-tetrahydrocortisol)/tetrahydrocortisone [(THF+5alpha-THF)/THE] by gas-chromatography in 29 NS patients with biopsy-proven glomerulonephritis and 29 healthy control subjects. The ratio of (THF+5alpha-THF)/THE was higher in NS patients (median 1.49, range 0.45-4.07) than in the control subjects (0.98, 0.60-1.36; p<0.01). This ratio was increased as a consequence of a decreased urinary excretion rate of the cortisone metabolite, THE. The present data indicate that a reduced activity of 11beta-HSD is a new mechanism contributing to the exaggerated sodium retention in patients with the NS.

11-beta-Hydroxysteroid Dehydrogenases↗

[Late dislocation of a plate haptic silicone lens into the vitreous body after Nd:YAG capsulotomy. A case report].

UNLABELLED: We describe a case that was referred 10 months after Nd:YAG laser treatment with a posteriorly dislocated silicone intraocular lens (IOL) into the vitreous cavity. PATIENT: A 70-year old white woman underwent uncomplicated phacoemulsification with in-the-bag placement of a Chiron silicone plate haptic lens through a 5.5- mm continuous circular capsulorhexis. The patient was fine until 9 months postoperatively when she complained of a decrease in visual acuity due to capsular fibrosis. A successful Nd:YAG laser capsulotomy was performed, resulting in an increase in visual acuity. Ten months later, the patient noted acute and atraumatic loss of vision, and the IOL was found to have dislocated posteriorly onto the retina. RESULTS: The dislocated IOL was removed via the anterior chamber following pars plana vitrectomy. Perfluorocarbon liquid was used to elevate the slippery lens from the retinal surface. The IOL was removed by a Sato Knife from the anterior chamber, followed by implantation of a one-piece PMMA IOL in the ciliary sulcus. CONCLUSION: Silicone plate haptic IOLs seem to present special risks for dislocation. Shrinkage of the anterior capsule exerts centripetal forces on the ends of the plate haptic, causing the optic to move posteriorly and to exert pressure against the posterior capsule. If either the posterior or anterior capsule is disrupted by Nd:YAG laser treatment, the forces created by capsular contraction against the flexible lens may cause extension of radial tears and appear to be a substantial risk for further capsule-tearing, releasing the IOL into the vitreous cavity, even months later. The forces of capsular contraction can impart a spring-loading effect on plate haptic silicone lenses. Due to inadequate capsular adherence, these lenses are at risk of posterior dislocation from capsular rents following Nd:YAG laser treatment.

Aged↗

[Adhesion of liquid perfluorocarbon to various intraocular lens materials. A light microscopy study].

INTRODUCTION: Perfluorocarbone liquids (PFCL) enable explantation of intraocular lenses (IOL) dislocated into the vitreous. Because of their relatively high specific weight, the IOL can be floated off the retina and repositioned in the anterior segment. If the IOL surface is affected by contact with PFCL is still unknown. We were interested in the extent of PFCL contact with different IOL materials, having in mind a repositioning of a dislocated IOL into the posterior chamber. We investigated the adherence of PFCL to different IOL surfaces. MATERIALS AND METHODS: The following IOL materials were tested: Group I: acrylate/methacrylate polymers: (a) PMMA, compression molding; (b) PMMA, compression molding, heparin-surface modified; (c) poly-hydroxyethylmethacrylate (polyHEMA); (d) phenylethylacrylate, phenylethylmethacrylate; (e) methylmethacrylate, HEMA; (f) methylmethacrylate, hydroxyethylmethacrylate, ethylene glycol dimethacrylate; (g) hydroxyhexylmethacrylate, HEMA. Group II: silicone elastomers: (a) polydimethylsiloxane; (b) polydimethyldiphenylsiloxane. A total of 17 types of standard quality IOLs were obtained from several manufacturers. Each IOL was immersed in PFCL for 3 h. Then each IOL was rinsed with 2 ml balanced salt solution (BSS) and investigated by light microscopy with regard to the extent of PFCL adhesion. RESULTS: After rinsing with BSS, no PFCL was detectable on any IOL surface. Possible PFCL invasion into an open optic-haptic junction in three-piece IOLs could not be excluded using this method. All IOLs demonstrated optic and haptic surfaces without alterations. The IOL surfaces were comparable to those of new IOLs. CONCLUSIONS: With respect to PFCL-IOL interaction, all IOLs seem to be inert. After luxation of the IOL into the vitreous and IOL elevation by using PFCL, repositioning of the dislocated IOL seems to be possible under special conditions (adequate total diameter, IOL without damage, no open haptic junction in the optic). After rinsing the explanted IOL with BSS prior to reimplantation, the risk of damaging the eye by PFCL remnants on the IOL appears neglibile.

Fluorocarbons↗

[An ophthalmologic image databank on the Internet].

The Internet has become a powerful, international source for information, and it has shown an exponential growth because of the ease of access and the immediate availability of information. We introduced a new ophthalmological atlas including ICD coding on the World Wide Web. So far, more than 500 lantern slides of typical and interesting ophthalmological findings have been selected and digitized. These pictures were integrated in a data base, which was arranged for ease and speed of search and retrieval. In its background, the data base contains a list of over 4700 ICD-encoded diagnoses to which the picture-documented findings are linked. Comments on pictures can be added by the author or by users. The data base contains several lists, such as a list of ICD codes and diagnoses, a list of all pictures with corresponding diagnoses, a list of all diagnoses and number of pictures, a list of those diagnoses for which the corresponding picture is available, as well as a list of comments on each picture. Special program scripts handle the user's search key words for diagnoses and extract the required information out of the data base, using Windows NT. Search results are presented on an automatically built-up webpage. To provide fast speed of search all pictures initially are shown in a small format (thumbnails) with little amount of data. The related full-size picture is retrieved by a single mouse click. Moreover, the name and institution of the author, diagnostical hints and comments on pictures by the author or by users are offered for each diagnosis available. The Giessen Ophthalmological Picture Atlas can be reached under www.med.unigiessen.de in the Internet. It allows a fast search free of charge from all over the world and, therefore, offers an additional option to obtain specific ophthalmological information for various purposes.

Databases, Factual↗

[Trabeculotomy, deep sclerectomy and viscocanalostomy. Non-fistulating microsurgical glaucoma operation ab externo].

Filtering procedures have been the gold standard in glaucoma surgery for more than 30 years. Trabeculotomy, deep sclerectomy, and viscocanalostomy might become the procedures of first choice in the future. These new, non-penetrating procedures have not yet been compared to filtering procedures in prospective randomized studies with long-term follow-up. In addition, it is not really known how they modify outflow of the aqueous humor. The surgical technique is described and the most likely underlying effects are discussed.

Adult↗

Effect of heparin in irrigating solution on inflammation following small incision cataract surgery.

PURPOSE: To study the effect of heparin-sodium added to the irrigating solution on postoperative inflammation in patients having cataract surgery. SETTING: Department of Ophthalmology, University of Giessen, Giessen, Germany. METHODS: Seventy-two patients having phacoemulsification with posterior chamber intraocular lens (IOL) implantation were randomly assigned to receive regular irrigating solution or solution with heparin-sodium (final diluted concentration 10 IU/mL). In half the patients, poly(methyl methacrylate) (PMMA) IOLs were implanted and in half, foldable silicone IOLs. The patients were examined preoperatively, on days 1 and 3, and 1 year postoperatively. Postoperative inflammation was objectively evaluated by measurement of flare and cells using laser flare-cell photometry. RESULTS: The mean postoperative flare values were significantly lower in the groups with additional heparin-sodium at days 1 and 3 (P < . 01). Flare values were not significantly different 1 year postoperatively. Cell values for the heparin-treated groups were lower, but the difference did not reach statistical significance. Flare and cells values for the two IOL materials were not significantly different during the entire follow-up. CONCLUSION: Heparin-sodium added to the infusion solution during small incision cataract surgery reduced inflammation in the early postoperative period.

Aged↗

Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study.

AIMS: This study investigated the effect of tissue plasminogen activator (tPA) in patients with severe intracameral fibrin after extracapsular cataract extraction or phacoemulsification with posterior chamber intraocular lens implantation. METHODS: A randomised prospective multicentre study was carried out in 86 patients with intraocular fibrin formation 2-8 days after cataract surgery. While the first group (n = 41) received only anti-inflammatory drugs, a single anterior chamber injection of tPA (10 micrograms) as an additional treatment to the standard was given in the second group (n = 44). On days 1, 2, 14, and 90 after randomisation, the visual acuities, slit lamp findings, and intraocular pressures were documented in standardised protocols. Efficacy of treatment was judged by the rate of fibrinolysis (primary objective), the frequency of synechiae, and central capsular fibrosis (secondary objectives). RESULTS: The incidence and quantity of intraocular fibrin were significantly lower in the patients treated with tPA than in the control group (p < 0.05). The frequencies of synechiae were reduced by tPA injection. The capsule fibrosis noted after 3 months was significantly lower in the tPA group (p = 0.027). No ocular side effects were noted after the tPA injections. CONCLUSIONS: Lysis of postcataract fibrin formation is accelerated and increased by a single intracameral injection of 10 micrograms tPA in addition to standard anti-inflammatory treatment. The findings suggest that the tPA injection reduces posterior capsule fibrosis, which still has to be addressed in larger study populations and with a long term follow up.

Adolescent↗

Furosemide inhibits 11beta-hydroxysteroid dehydrogenase type 2.

11Beta-hydroxsteroid dehydrogenase 2 (11beta-OHSD2) protects the nonselective renal mineralocorticoid receptor from the endogenous glucocorticoid cortisol. Thus, drugs inhibiting 11beta-OHSD2 might enhance urinary loss of potassium. As diuretics influence the renal handling of potassium, we analyzed the impact of 13 commonly used diuretics on 11beta-OHSD2. Furosemide was the only inhibitor. Its inhibition constant (Ki) was 30 micromol when extracts from COS-1 cells transfected with human 11beta-OHSD2 were used as an enzyme source. The type of inhibition was competitive. To establish whether furosemide inhibits 11beta-OHSD2 and 11beta-OHSD1 in the renal target tissue, isolated tubular segments from rats were analyzed. Furosemide decreased the oxidative activity of 11beta-OHSD2 in intact distal tubules and 11beta-OHSD1 in proximal convoluted tubules. For the assessment of furosemide on the excretion of corticosterone metabolites in vivo, rats were given furosemide i.p., and the ratio of tetrahydrocorticosterone plus 5alpha-tetrahydrocorticosterone to 11-dehydrotetrahydrocorticosterone was determined in urine. This ratio increased after the administration of furosemide in all animals, indicating inhibition of the oxidative activity of 11beta-OHSD. Thus, furosemide inhibits the 11beta-OHSD2 enzyme in the target tissue and might by that mechanism enhance the mineralocorticoid effect of 11beta-hydroxyglucocorticoids.

11-beta-Hydroxysteroid Dehydrogenases↗

[Ocular pulse amplitude and local carbonic anhydrase inhibition].

UNLABELLED: Ocular perfusion is increasingly being discussed in the pathogenesis of glaucoma. The present study was designed to investigate ocular pulse amplitude (OPA) in primary open-angle glaucoma (POAG) patients with elevated intraocular pressure (HTG) and non-glaucomatous controls (CTL) following topical application of the carbonic anhydrase inhibitor dorzolamide. METHODS: OPA (Ocular Blood Flow System, OBF Labs UK) intraocular pressure (IOP), heart rate (HR), and systolic (BPsyst) and diastolic (BPdiast) bronchial artery pressures were measured before and 2 days after initiating treatment in 33 cataract patients with n = 14) and without (n = 19) POAG. RESULTS: Following application of dorzolamide, IOP (mmHg) in drug-treated HTG and CTL eyes was highly significantly reduced (p < 0.001) and in vehicle-treated HTG and CTL eyes significantly reduced (p < 0.03) compared to respective baseline measurements. OPA (mmHg) in drug-treated HTG and CTL eyes was significantly increased (p < 0.05) and in vehicle-treated eyes in affected compared to respective baseline measurements. Systemic perfusion parameters were also unchanged. CONCLUSION: Dorzolamide increased OPA in HTG and CTL eyes. An increase in OPA may improve the prognosis of HTG.

Adult↗

[Long-term stability of heparin-coated PMMA intraocular lenses. Results of an in vitro study].

UNLABELLED: The surface modification of PMMA-intraocular lenses (IOLs) demonstrated a blood-aqueous-barrier protective effect and reduced the incidence of IOL depositions and postoperative fibrin exudation, especially in risk patients (e.g. pediatric cataract, diabetes mellitus, recurrent uveitis). The long-term stability of the surface modification via phenylimines, which permit a covalent surface linkage of heparin to synthetic polymeric materials by reductive amination, is still unknown. MATERIAL AND METHODS: Four heparin surface-modified (HSM) monofocal and two unmodified monofocal sterile PMMA-IOLs were stored in an aqueous-serum mixture at 37 degrees C over a period of 4 years and 1 months with daily rotation. After 4 years the concentration of surface-bound heparin on two HSM-IOLs of this mixture and two brand-new HSM-IOLs were determined using an orcin-assay after initial heparinase treatment. Four years after incubation, the modified toluidine blue staining method was used to examine the surface-bound heparin on synthetic polymers. This staining technique with toluidine blue, a non-protein basic substance, enables examination and analysis of the homogeneity of the mono-molecular heparin layer even under critical conditions because of its homogeneous staining. Light and scanning electron microscopic examination of the IOL surfaces were subsequently performed. RESULTS: The concentration of heparin (microgram/cm2) on the IOL surface after 4 years of incubation and treatment with heparinase was valued at 0.51 +/- 0.05 and 0.53 +/- 0.04 in the two brand-new HSM-IOLs. A slightly coarsegrained complex agglutination on the IOL surface was detected by the toluidine blue staining method. Light and spectral microscopy of the surface of the stained IOLs as well as scanning electron microscopy of all HSM-IOLs showed a homogeneous heparin structure and coating after 4 years of in vitro storage. No signs of desorption or reduced reactivity of the heparin were observed in comparison with new HSM-IOLs. The unmodified PMMA-IOLs did not stain, as expected. CONCLUSION: The heparin-modified surface of the examined PMMA-IOLs was intact even after 4 years of storage in an aqueous serum solution. A long-term benefit, in addition to the advantages of the hydrophilisation in the immediate postoperative period, especially for risk patients, is therefore suggested.

Drug Stability↗